The automated systems for glycemic control include a variety of devices such as insulin pumps, artificial
pancreas and insulin pens. The demand for these devices is on the rise owing to the flexibility, accurate
dosage, automatic detection of glucose level, short and rapid acting insulin and convenient usage. The
presence of large base of children and geriatric population within the target customer group is
propelling the market.
Artificial Pancreas Market Covers the Table of Contents With Segments, Key Players And Region. Based
on Product Type, Artificial Pancreas Market is sub segmented into CTR System, CTT System, Threshold
suspended device system. On the Basis of Application, Market is sub segmented into Hospitals and
Clinics.
Major Players profiled in the Artificial Pancreas Market report incorporate: Medtronic Plc, Bigfoot
Biomedical, Johnson & Johnson, Tandem Diabetes Care, Pancreum, TypeZero Technologies, Beta Bionics
Top Industry for Artificial Pancreas Market News
Beta Bionics, Inc. and Zealand Pharma announced today that a home-use study of dasiglucagon in the
iLet Bionic Pancreas System has been successfully completed. The iLet, developed by Beta Bionics, is the
world’s first autonomous bionic pancreas device — a bihormonal system leveraging lifelong machine
learning and artificial intelligence to deliver insulin and glucagon analogs for the autonomous treatment
of type 1 diabetes (T1D). In addition to dosing insulin, the iLet doses dasiglucagon — a glucagon analog
with a unique stability profile in a ready-to-use aqueous solution. Dasiglucagon is in development by
Zealand Pharma.
The iLet operated as expected, meeting the primary aim of the study. Preliminary data analysis
demonstrated that the bihormonal iLet using dasiglucagon provided superior glycemic control over the
insulin-only iLet. During the bihormonal period, participants achieved a mean glucose level, as measured
by continuous glucose monitoring (CGM), of 139 mg/dL on days 2–7 of use, versus 149 mg/dL during the
insulin-only period (p <0.01).
Request a Discount on standard prices of this premium report @
https://www.businessindustryreports.com/check-discount/164050 .
Region segment: This report is segmented into several key regions, with sales, revenue, market share
(%) and growth Rate (%) of Artificial Pancreas in these regions, from 2014 to 2023 (forecast), covering:
North America, Europe, Asia Pacific, Middle East & Africa and South America.
Significant points in table of contents: Market Definition, Market Overview, Business Introduction,
Segmentation (Region Level), Segmentation (Type Level), Segmentation (Industry Level), Segmentation
(Channel Level), Market Forecast Year, Segmentation Type, Segmentation Industry, Market Cost
Analysis, and Conclusion.
Report contents include
1 Analysis of the Artificial Pancreas Market including revenues, future growth, market outlook